{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:10:16Z","timestamp":1762542616140},"reference-count":33,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T00:00:00Z","timestamp":1485216000000},"content-version":"vor","delay-in-days":23,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"published-print":{"date-parts":[[2017]]},"DOI":"10.1016\/j.medici.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T04:00:20Z","timestamp":1486094420000},"page":"34-39","source":"Crossref","is-referenced-by-count":7,"title":["VEGF-A, sVEGFR-1, and sVEGFR-2 in BCR-ABL negative myeloproliferative neoplasms"],"prefix":"10.3390","volume":"53","author":[{"given":"Gra\u017cyna","family":"Gadomska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Stankowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Boinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"\u015alusarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marzena","family":"Tylicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Michalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Jachalska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danuta","family":"Ro\u015b\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","reference":[{"issue":"7","key":"10.1016\/j.medici.2017.01.004_bib0165","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2011-02-292102","article-title":"New mutations and pathogenesis of myeloproliferative neoplasms","volume":"118","author":"Vainchenker","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.medici.2017.01.004_bib0170","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2004.05291.x","article-title":"The crucial role of vascular permeability factor\/vascular endothelial growth factor in angiogenesis: a historical review","volume":"128","author":"Ribatti","year":"2005","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.medici.2017.01.004_bib0175","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ijos.2012.33","article-title":"The role of vascular endothelial growth factor in ossification","volume":"4","author":"Yang","year":"2012","journal-title":"IJOS"},{"issue":"5","key":"10.1016\/j.medici.2017.01.004_bib0180","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2990.2004.00600.x","article-title":"Vascular endothelial growth factor and the nervous system","volume":"30","author":"Brockington","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"9","key":"10.1016\/j.medici.2017.01.004_bib0185","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1182\/blood-2004-01-0226","article-title":"Targeting autocrine and paracrine VEGF receptor pathway inhibits human lymphoma xenografts in vivo","volume":"104","author":"Wang","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.medici.2017.01.004_bib0190","first-page":"189","article-title":"Assessment of sVEGFR-1 concentration in patients with breast cancer","volume":"14","author":"Thielemann","year":"2010","journal-title":"Wsp\u00f3\u0142cz Onkol"},{"issue":"10","key":"10.1016\/j.medici.2017.01.004_bib0195","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1177\/154405910708601006","article-title":"VEGF: an essential mediator of both angiogenesis and endochondral ossification","volume":"86","author":"Dai","year":"2007","journal-title":"J Dent Res"},{"issue":"3","key":"10.1016\/j.medici.2017.01.004_bib0200","first-page":"149","article-title":"Circulating VEGF and its soluble receptors sVEGFR-1 and sVEGFR-2 in patients with acute leukemia","volume":"14","author":"Wierzbowska","year":"2003","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.medici.2017.01.004_bib0205","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/1471-2407-14-696","article-title":"Serum angiopoietin-2 and soluble VEGFR-2 levels predict malignancy of ovarian neoplasm and poor prognosis in epithelial ovarian cancer","volume":"14","author":"Sallinen","year":"2014","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.medici.2017.01.004_bib0325","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.medici.2017.01.004_bib0210","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.lungcan.2005.09.005","article-title":"Angiogenesis In non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood","volume":"51","author":"Bremnes","year":"2006","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.medici.2017.01.004_bib0215","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/sj.bjc.6603143","article-title":"Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases","volume":"94","author":"Lesslie","year":"2006","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.medici.2017.01.004_bib0220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<178::AID-CNCR25>3.0.CO;2-7","article-title":"Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease","volume":"85","author":"Kraft","year":"1999","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.medici.2017.01.004_bib0225","first-page":"197","article-title":"Vascular endothelial growth factor (VEGF) and its role in B-cell chronic lymphocytic leukemia","volume":"39","author":"W\u0105sik-Szczepanek","year":"2008","journal-title":"Acta Haematol Pol"},{"issue":"9","key":"10.1016\/j.medici.2017.01.004_bib0230","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/cncr.10900","article-title":"Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes","volume":"95","author":"Aguayo","year":"2002","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.medici.2017.01.004_bib0235","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1365-2141.2002.03551.x","article-title":"Clinical relevance of vascular endothelial growth factors 1 and 2 in acute myeloid leukemia and myelodysplastic syndrome","volume":"118","author":"Verstovsek","year":"2002","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.medici.2017.01.004_bib0240","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1182\/blood.V97.5.1427","article-title":"Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes","volume":"97","author":"Bellamy","year":"2001","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.medici.2017.01.004_bib0245","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2009.07726.x","article-title":"Angiogenesis and vascular endothelial growth factor -\/receptor expression in myeloproliferative neoplasms: correlation with clinical parameters and JAK2-V617F mutational status","volume":"146","author":"Medinger","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.medici.2017.01.004_bib0250","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1309\/FP0N3LC8MBJUFFA6","article-title":"VEGF expression correlates with microvessel density in Philadelphia chromosome-negative chronic myeloproliferative disorders","volume":"128","author":"Gianelli","year":"2007","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.medici.2017.01.004_bib0255","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2040-2384-2-10","article-title":"Clinical trials with anti-angiogenic agents in hematological malignancies","volume":"2","author":"Medinger","year":"2010","journal-title":"J Angiogenes Res"},{"issue":"9","key":"10.1016\/j.medici.2017.01.004_bib0260","first-page":"471","article-title":"Angiogenesis in different clinical phases of chronic myeloid leukemia","volume":"66","author":"Krasowska-Kwiecie\u0144","year":"2009","journal-title":"Przegl Lek"},{"key":"10.1016\/j.medici.2017.01.004_bib0265","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajh.10020","article-title":"Soluble angiogenic factor: implications for chronic myeloproliferative disorders","volume":"69","author":"Musolino","year":"2002","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.medici.2017.01.004_bib0270","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.patbio.2010.02.005","article-title":"Evaluation of serum VEGF levels in untreated erythrocytosis patients","volume":"59","author":"Maktouf","year":"2011","journal-title":"Pathol Biol (Paris)"},{"issue":"4","key":"10.1016\/j.medici.2017.01.004_bib0275","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/hon.865","article-title":"Evaluation of circulating endothelial cells, VEGF and VEGFR2 serum levels in patients with chronic myeloproliferative diseases","volume":"26","author":"Alonci","year":"2008","journal-title":"Hematol Oncol"},{"issue":"6","key":"10.1016\/j.medici.2017.01.004_bib0280","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10245330701554664","article-title":"Serum levels, and bone marrow immunohistochemical expression of, vascular endothelial growth factor in patients with chronic myeloproliferative diseases","volume":"12","author":"Panteli","year":"2007","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.medici.2017.01.004_bib0285","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/10245330500065797","article-title":"Soluble VEGF\/sFLt1 ratio is an independent predictor of AML patient outcome","volume":"10","author":"Aref","year":"2005","journal-title":"Hematology"},{"issue":"2","key":"10.1016\/j.medici.2017.01.004_bib0290","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1073\/pnas.94.2.663","article-title":"Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets","volume":"94","author":"M\u00f6hle","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.medici.2017.01.004_bib0295","article-title":"Evaluation of vascular endothelial growth factor, fibroblast growth factor and thrombopoietin serum levels in myeloproliferative diseases","author":"Misso","year":"2007","journal-title":"Congr Eur Hematol Assoc"},{"issue":"9","key":"10.1016\/j.medici.2017.01.004_bib0300","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/cncr.20187","article-title":"Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes","volume":"100","author":"Hu","year":"2004","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.medici.2017.01.004_bib0305","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1046\/j.1365-2141.1998.01076.x","article-title":"Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth","volume":"103","author":"Ratajczak","year":"1998","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.medici.2017.01.004_bib0310","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s12185-010-0596-7","article-title":"Circulating endothelial cells in essential thrombocythemia and polycythemia vera: correlation with JAK2-V617F mutational status, angiogenic factors and coagulation activation markers","volume":"91","author":"Treli\u0144ski","year":"2010","journal-title":"Int J Hematol"},{"issue":"3","key":"10.1016\/j.medici.2017.01.004_bib0315","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1582-4934.2009.00941.x","article-title":"A systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use","volume":"14","author":"Wu","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"3","key":"10.1016\/j.medici.2017.01.004_bib0320","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/jcp.2010.083386","article-title":"Increased expression of vascular endothelial growth factor receptor 1 correlates with VEGF and microvessel density in Philadelphia chromosome-negative myeloproliferative neoplasms","volume":"64","author":"Boiocchi","year":"2011","journal-title":"J Clin Pathol"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X17300046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1010660X17300046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T07:15:21Z","timestamp":1719040521000},"score":1,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1010660X17300046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"alternative-id":["S1010660X17300046"],"URL":"https:\/\/doi.org\/10.1016\/j.medici.2017.01.004","relation":{},"ISSN":["1010-660X"],"issn-type":[{"value":"1010-660X","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}